ANEST IWATA Corporation
Notice regarding the status of share buyback
Repurchased shares. Shares acquired: 342,900 common shares, total amount: 602,525,800 yen, period: 2026/7/1 to 2026/7/31, method: market purchases. As a reference, the Board of Directors resolved on 2026/5/12 with an upper limit of 1,000,000 shares and 1.5 billion yen, acquisition period from 2026/5/13 to 2026/12/31, cumulative total: 550,800 shares and 943,578,700 yen acquired to date.
Key Figures
- 342,900 shares: Total number of shares acquired
- 602,525,800 yen: Total value of share acquisitions
- July 1, 2026 to July 31, 2026: Acquisition period
- 550,800 shares: Cumulative shares acquired (as of 2026/7/31)
- 943,578,700 yen: Cumulative total acquired (as of 2026/7/31)
AI要約
Overview of capital policy
Anest Iwata is advancing its share buyback, acquiring 342,900 ordinary shares via market purchases during the period July 1, 2026 to July 31, 2026. The total amount is 602,525,800 yen. In the Board resolution dated May 12, 2026, the upper limit was set at 1,000,000 shares and 1.5 billion yen, with the acquisition period from May 13, 2026 to December 31, 2026; the current cumulative total is 550,800 shares and 943,578,700 yen. Announcement date: August 4, 2026.
Impact on shareholders and outlook
Share buybacks are often positioned as a means of shareholder returns, aiming to curb dilution and enhance shareholder value. The cumulative acquisition status and amount have been disclosed, and the progress of shareholder returns will depend on any additional acquisitions and their scale. The method is market purchases, which provides high transparency, and the period is clearly defined.
Anest Iwata Corporation
Company overview · Stock price · Financial data · All IR
